Stock A328130 LUNIT INC.
Add to a list
To use this feature you must be a member
Log inSign up

Lunit Inc. Stock

Equities

A328130

KR7328130000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
56,900 KRW -1.04% Intraday chart for Lunit Inc. +4.40% -30.53%
04:07pm Lunit to Showcase 7 Studies at Asco 2024, Including Ai Innovations in Her2 Quantification, and Multimodal Predictive Models for Immunotherapy Response CI
May. 23 Lunit Acquires New Zealand's Volpara Health Technologies MT

Financials

Sales 2024 * 53.55B 39.2M Sales 2025 * 96.38B 70.55M Capitalization 1,640B 1.2B
Net income 2024 * -15B -10.98M Net income 2025 * 12B 8.78M EV / Sales 2024 * 27.5 x
Net cash position 2024 * 170B 124M Net cash position 2025 * 180B 132M EV / Sales 2025 * 15.2 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 74.08%
More Fundamentals * Assessed data

Chart Lunit Inc.

Dynamic Chart

Latest news about Lunit Inc.

Lunit to Showcase 7 Studies at Asco 2024, Including Ai Innovations in Her2 Quantification, and Multimodal Predictive Models for Immunotherapy Response CI
Lunit Acquires New Zealand's Volpara Health Technologies MT
Volpara to Delist After Court Approves Acquisition by Lunit MT
Lunit Wins Shareholder Approval for Volpara Health Takeover MT
Volpara Health Technologies Secures Approval for Lunit’s Proposed Takeover MT
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals CI
Lunit Announces Publication of New Study Featuring Lunit SCOPE IO CI
Lunit Announces Two Commercial Deals Signal its Expansion in Europe CI
Lunit Inc. Receives Two Supply Contracts That Mark Its Strategic Expansion into the East and Southeast Asian Region CI
Lunit Announces Three-Year Supply Contract with Samsung Electronics CI
GC Cell Signs Agreement with Lunit for AI-Powered Cancer Treatment MT
Lunit to Take Over Volpara Health; Lunit Shares Decline 4% MT
Lunit Inc. agreed to acquire Volpara Health Technologies Limited from Harbour Asset Management Limited and others for AUD 300 million. CI
Lunit Inc. Partners with NTT DATA Singapore to Introduce Lunit Insight CXR to Singapore's Public Healthcare System CI
Lunit Unveils Prognostic Insights for Colon Cancer - Published in Npj Precision Oncology CI
More news

Press releases Lunit Inc.

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients AQ
Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment, New Study in Breast Cancer Research AQ
Lunit Presents Seven Study Results at ECR 2024, Showcasing AI's Robust Performance in Diverse Clinical Settings AQ
New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy across Diverse Tumors, published in the JITC AQ
Lunit INSIGHT CXR Excels in Long Nodule Detection, Exceptional Performance in Head-to-Head Study published in Radiology AQ
More press releases

Quotes and Performance

1 day-1.04%
1 week+4.40%
Current month+0.71%
1 month+7.77%
3 months-15.58%
6 months-36.99%
Current year-30.53%
More quotes

Highs and lows

1 week
52 300.00
Extreme 52300
60 300.00
1 month
51 800.00
Extreme 51800
60 300.00
Current year
47 150.00
Extreme 47150
82 800.00
1 year
39 300.00
Extreme 39300
139 750.00
3 years
9 450.00
Extreme 9450
139 750.00
5 years
9 450.00
Extreme 9450
139 750.00
10 years
9 450.00
Extreme 9450
139 750.00
More quotes

Managers and Directors - Lunit Inc.

Managers TitleAgeSince
Beom-Seok Suh CEO
 Chief Executive Officer 41 15-12-31
Jung-Min Lee FOU
 Founder - 13-08-23
Seung-Wook Baek FOU
 Founder 41 13-08-23
Members of the board TitleAgeSince
Garheng Kong BRD
 Director/Board Member 49 21-10-31
Seung-Wook Baek FOU
 Founder 41 13-08-23
Beom-Seok Suh CEO
 Chief Executive Officer 41 15-12-31
More insiders

ETFs positioned on Lunit Inc.

Name Weight AuM 1st Jan change Investor Rating
SIMPLIFY EMERGING MARKETS PLUS DOWNSIDE CONVEXITY ETF - USD ETF Simplify Emerging Markets Plus Downside Convexity ETF - USD
0.01% 4 M€ -4.41% -
More ETFs positioned on Lunit Inc.

Quotes

Date Price Change Volume
24-05-23 56,900 -1.04% 192 254
24-05-23 57,500 +1.05% 364,651
24-05-22 56,900 +5.96% 884,172
24-05-21 53,700 -1.29% 185,250
24-05-20 54,400 -0.55% 175,918

End-of-day quote Korea S.E., May 23, 2024

More quotes

Company Profile

Lunit Inc is a Korea-based company principally engaged in the development and supply of medical software. The Company is principally engaged in the development and supply of medical software such as cancer diagnostic aid solutions, cancer early detection solutions, cancer risk prediction solutions and others through artificial intelligence (AI) technologies.
Sector
Advanced Medical Equipment & Technology
Calendar
2024-08-10 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Lunit Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
56,900 KRW
Average target price
100,000 KRW
Spread / Average Target
+75.75%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
LUNIT INC. Stock Lunit Inc.
-30.53% 1.21B
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+5.88% 33.06B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+20.73% 7.99B
SECTRA AB Stock Sectra AB
+34.25% 4.34B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-29.79% 2.62B
OMNICELL, INC. Stock Omnicell, Inc.
-12.58% 1.46B
VERADIGM INC. Stock Veradigm Inc.
-27.55% 1.31B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+11.30% 993M
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-38.17% 883M
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-23.12% 686M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. A328130 Stock